Back

Long-term evolution of Fabry cardiomyopathy under enzyme replacement therapy in the Swiss Fabry cohort. An echocardiographic study

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Pierre Monney

University Hospital Centre Vaudois (CHUV), Lausanne (Switzerland)

9 More presentations in this session

Presentation thumbnail
Apical sparing in patients without cardiac amyloidosis
Ms C. Binder (Vienna, AT)
Abstract
Presentation thumbnail
Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
Doctor R. Rettl (Vienna, AT)
Abstract Slides
Presentation thumbnail
Diagnostic utility of tissue biopsy in transthyretin cardiac amyloidosis diagnosed by non-invasive diagnostic criteria
Doctor M. Nishi (Kumamoto, JP)
Abstract
Presentation thumbnail
Association of acroparesthesias and angiokeratomas with the alpha-galactosidase A gene polymorphisms in females with hypertrophic cardiomyopathy
Miss A. Polyakova (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Electrocardiographic findings in Anderson-Fabry disease versus sarcomeric hypertrophic cardiomyopathy
Doctor G. Vitale (Bologna, IT)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Inflammatory, infiltrative and cardiomyopathy

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources